InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
59,868.95
(
-1.17%
)
Post# of 253121
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Bio_pete

Send PM Follow Ignore
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Bio_pete

Re: DewDiligence post# 48579

Friday, 06/15/2007 11:25:05 PM

Friday, June 15, 2007 11:25:05 PM

Post# of 253121
ENCY/GILD - How does the FDA approve a drug with significant safety issues, but fails to approve another drug for the same indication for failure to demonstrate effectiveness when three regulatory agencies have not questioned the efficacy data? The agency even admits that the data indicates an improved exercise tolerance. Somethings wrong with this picture.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up